The Woodworkers You Don't Want: Inside the World of Carpenter Ants with Orkin Canada

TORONTO, May 13, 2026 (GLOBE NEWSWIRE) -- With spring here, homeowners across Canada may begin noticing increased ant activity in and around their homes. While many ants are harmless, experts warn that carpenter ants are one pest that should never be ignored.

GlobeNewsWire • 11 hours ago

Rollins To Host 2026 Investor and Analyst Conference on May 14th

ATLANTA, May 7, 2026 /PRNewswire/ -- Rollins, Inc. (NYSE:ROL) ("Rollins" or the "Company"), a premier global consumer and commercial services company, will hold its 2026 Investor and Analyst Conference on Thursday, May 14, at 9 a.m. Eastern Time.

PRNewsWire • May 7, 2026

Rollins: Demand Held Up, But Ebitda Impacted By Non-Structural Reasons

Rollins remains a buy as growth momentum and demand resilience persist, despite a noisy Q1 2026 margin miss. Q1 2026 revenue grew ~10% y/y to $906.4M, with organic growth across all segments and a swift March rebound after weather disruptions. Adj. EBITDA margin fell 109 bps to 19.8%, but margin weakness is attributed to non-structural, transient cost factors likely to normalize.

Seeking Alpha • May 7, 2026

Los Angeles Holds Top Spot as Worst City for Mosquitoes as Activity Climbs Nationwide

A decade ago, Atlanta led the nation in mosquito activity—in its 6 th year running, Los Angeles has firmly taken that title ATLANTA, May 5, 2026 /PRNewswire/ -- As mosquito season kicks off across the U.S., Orkin's 2026 Mosquito Cities List reveals a significant shift in mosquito activity across the U.S. and where these unwelcome pests are making the biggest buzz. While Los Angeles, Chicago and New York hold the top three spots, the broader top 50 list shows mosquito activity expanding beyond traditional hotspots and reaching more regions across the country.

PRNewsWire • May 5, 2026

Polen Focus Growth Portfolio Q1 2026 Portfolio Update

In Q1 2026, Polen Focus Growth Portfolio returned -17.27% (net of fees) compared to -9.78% for the Index. Starbucks was the top performing absolute and relative contributor in Q1 amid positive signs that CEO Brian Nicol's multi-year turnaround strategy is beginning to bear fruit. In Q1 2026, we initiated new positions in Lam Research, Meta and Rollins, while we sold our holdings in Abbott Laboratories, Adobe, and Boston Scientific, Paycom and Intuit.

Seeking Alpha • May 4, 2026

Innovations & Strategic Buyouts Aid Rollins Amid Integration Risk

ROL's growth rides on tech-driven efficiency and steady acquisitions. Its rising costs, integration risks and liquidity concerns could weigh on margins.

Zacks Investment Research • May 1, 2026

Rollins (ROL) is a Top-Ranked Momentum Stock: Should You Buy?

The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.

Zacks Investment Research • Apr 28, 2026

Here's Why Rollins (ROL) is a Strong Growth Stock

Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.

Zacks Investment Research • Apr 27, 2026

Rollins: Despite Margin Declines, I Remain Confident In This Niche Market Leader

Rollins, Inc. in Q1 2026 saw 10% revenue growth (6.6% organic), with management reaffirming 7–8% organic and 2–3% M&A growth targets. Recent acquisitions, notably Romex for $90M, expand ROL's southern U.S. footprint and reinforce its M&A-driven growth strategy. Rollins remains a high-quality business yet trades at a premium P/E. I plan to add more shares if the stock falls to or below $50.

Seeking Alpha • Apr 27, 2026

Rollins, Inc. (ROL) Q1 2026 Earnings Call Transcript

Rollins, Inc. (ROL) Q1 2026 Earnings Call Transcript

Seeking Alpha • Apr 23, 2026